KYNB
Kyntra Bio, Inc.
There isn't enough reported data to score KYNB yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
KYNB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
KYNB's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
KYNB PE Valuation
KYNB has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
KYNB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| -- | |
| Limited | |
| Low |
Analysts expect KYNB's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
KYNB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $45.20 | +$45.58 |
| Q1 2026 | $40.36 | +$42.86 |
| Q4 2025 | $45.37 | +$57.37 |
| Q3 2025 | $53.48 | +$83.98 |
| Q2 2025 | -$0.38 | +$42.12 |
| Q1 2025 | -$2.50 | +$58.50 |
| Q4 2024 | -$12.00 | +$61.00 |
| Q3 2024 | -$30.50 | +$46.00 |
KYNB has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
KYNB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $3.7M | +36% |
| Q2 2025 | $1.3M | -97% |
| Q1 2025 | $2.7M | -95% |
| Q3 2024 | $46.3M | +15% |
| Q2 2024 | $50.6M | +14% |
| Q1 2024 | $55.9M | +55% |
| Q4 2023 | $27.1M | -21% |
| Q3 2023 | $40.1M | +155% |
UNH has the stronger quarterly revenue trend. Revenue is down 154% for KYNB versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -370% | +175 points |
| Q4 2025 | -1058% | N/A |
| Q2 2025 | -894% | -873 points |
| Q1 2025 | -545% | -489 points |
| Q3 2024 | -36% | +122 points |
| Q2 2024 | -22% | +177 points |
| Q1 2024 | -56% | +155 points |
| Q4 2023 | -200% | -7.2 points |
KYNB's operating margin was −370% last quarter, down 333 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
KYNB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4M | -132% |
| Q1 2026 | -$13.9M | -614% |
| Q4 2025 | -$18.3M | +$12.3M |
| Q3 2025 | -$1.9M | +$6.6M |
| Q2 2025 | $12.7M | +$52.6M |
| Q1 2025 | $2.7M | +$62M |
| Q4 2024 | -$30.6M | -$12M |
| Q3 2024 | -$8.5M | +$76.8M |
KYNB has burned cash in almost every quarter: −$38M over the past year, against −$24M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over KYNB on cash generation, producing positive trailing cash flow while its opponent burns cash.
KYNB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1K shares |
| 1 year | +0.1% | +6K shares |
| 3 years | +3.6% | +139K shares |
| 5 years | +9.7% | +357K shares |
| Available history | +16% | +568K shares |
KYNB has 4M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $5,000 |
| Q4 2024 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over KYNB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
KYNB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2019 | -4.7x | Net Cash |
KYNB has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
KYNB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.1 | Oversold |
| Stochastic | 3.4 | Oversold |
KYNB's weekly RSI is 25 (oversold) and its Stochastic is 3 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
KYNB PE vs Healthcare Sector
| Metric | KYNB | Sector median | Relative |
|---|---|---|---|
| PE | 0.1x | 26x | 100% below |
| PE % | 0 | 29 | 29 pts below |
KYNB has the edge over UNH on valuation relative to its sector.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
KYNB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.09 | 29% below |
| 20 week MA | $6.52 | 45% below |
| 50 week MA | $7.17 | 50% below |
| 100 week MA | $8.50 | 58% below |
| 200 week MA | $70.4 | 95% below |
KYNB is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over KYNB on trend strength, trading above more of its moving averages.
KYNB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,122.3 | $1,010.3 | -10% |
| 2021 | $1,010.3 | $384.8 | -62% |
| 2022 | $384.8 | $390.3 | +1.4% |
| 2023 | $390.3 | $22.2 | -94% |
| 2024 | $22.2 | $14.5 | -35% |
| 2025 | $14.5 | $8.90 | -39% |
| 2026 YTD | $8.90 | $3.59 | -60% |
KYNB has finished three years in a row lower, and it's down 60% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over KYNB on returns for 2026, with the stronger performance.